Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/1/2026

Long‑Term Prednisone 5 mg Daily: Bone Protection, Monitoring, and Safe Tapering

Essential Bone‑Protection Measures

  • All adults receiving ≥5 mg prednisone daily for ≥3 months should be given calcium (1,000–1,200 mg elemental) and vitamin D (600–800 IU daily, or enough to keep serum 25‑OH‑D ≥30–50 ng/mL). Grade A recommendation with strong evidence. [1][2][3][4]
  • Perform a baseline DXA scan of the lumbar spine and hip at therapy start and repeat every 1–2 years while on steroids. [3][4]5
  • Initiate bisphosphonate therapy (alendronate or risedronate) for osteoporosis prevention in patients at high fracture risk (post‑menopausal women, men > 50 yr, or those with pre‑existing osteoporosis). [1][2]6
  • Calculate a FRAX score for every adult beginning chronic prednisone to identify those who would benefit from early bisphosphonate initiation. 6
  • Bisphosphonates are strongly recommended when bone‑mineral density is below the normal range. 2

Routine Monitoring of Glucocorticoid‑Related Complications

  • At each clinical visit record body weight and blood pressure. 1
  • Check serum lipid profile periodically. 1
  • Monitor blood glucose (or urine glucose) according to individual risk factors. 1

Vaccination Recommendations

  • Administer seasonal influenza, H1N1, and pneumococcal vaccines to all patients on long‑term glucocorticoids. 7
  • Live‑attenuated vaccines are contraindicated in immunosuppressed patients. 7

Steroid‑Sparing and Disease‑Specific Strategies

  • Aim to use the lowest effective prednisone dose that maintains disease control. 5

Autoimmune Hepatitis (when applicable)

  • Maintenance therapy consists of prednisone 5–10 mg daily plus azathioprine 1–2 mg/kg/day. [3][4]5
  • Continue this regimen for at least 2 years and for a minimum of 12 months after liver enzymes have normalized. [3][4]
  • Consider a liver biopsy to confirm histologic remission before attempting drug withdrawal. [3][4]
  • Monitor liver enzymes every 3–4 months during the maintenance phase. 8

Withdrawal Considerations and Tapering Protocol

  • Do not stop prednisone abruptly after long‑term use; a gradual taper is required to avoid adrenal insufficiency (HPA‑axis suppression may persist up to 12 months) and glucocorticoid‑withdrawal syndrome (myalgia, arthralgia, malaise). 9
  • Tapering steps:
    • >300 nmol/L (10 µg/dL): HPA‑axis recovery; prednisone can be stopped.
    • 150–300 nmol/L (5–10 µg/dL): Continue physiologic dose; retest in weeks‑months.
    • <150 nmol/L (5 µg/dL): Continue physiologic dose; retest after several months. 9

General Safety Practices

  • Osteoporosis prevention measures (calcium, vitamin D, DXA, bisphosphonates) should start at therapy initiation, not after fractures develop. [1][2]
  • Even low‑dose prednisone (≤5 mg) requires regular monitoring and bone‑protection after 3 months of therapy. [1][2]
  • Patients should carry a glucocorticoid identification card and be educated about stress‑dose steroids for acute illness or surgery. 3

Peri‑operative Glucocorticoid Coverage

  • For patients on glucocorticoids >1 month, provide peri‑operative glucocorticoid replacement to prevent adrenal crisis during surgery. 1